Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IPL | Ann: Investore Property Limited (NS) ("IPL010") - Maturity | 28/03/24 | 0 | 54 | |||
|
|||||||
IPL | Ann: IPL010 Bond Maturity | 28/03/24 | 0 | 41 | |||
|
|||||||
IPL | Ann: D&O Ongoing Disclosure | 18/03/24 | 0 | 36 | |||
|
|||||||
IPL | Ann: Allotment of Dividend Reinvestment Plan Securities | 18/03/24 | 0 | 33 | |||
|
|||||||
IPL | Ann: Dividend Reinvestment Plan Issue Price Set | 06/03/24 | 0 | 49 | |||
|
|||||||
IPL | Ann: FY24 Third Quarter Dividend | 21/02/24 | 0 | 51 | |||
|
|||||||
IPL | Ann: D&O Ongoing Disclosure | 13/12/23 | 0 | 81 | |||
|
|||||||
IPL | Ann: Allotment of Dividend Reinvestment Plan Securities | 12/12/23 | 0 | 65 | |||
|
See All Discussions